|Mr. Richard M. Rumble||Pres, CEO & Director||411.57k||N/A||1959|
|Mr. Glen Kayll||Chief Financial Officer||238.44k||N/A||1969|
|Mr. Harold R. Tessman||Chief Operations Officer||229.06k||N/A||N/A|
|Dr. Bradley J. Catalone MBA, Ph.D.||Chief Scientific Officer||231.83k||N/A||N/A|
|Ms. Cindy Clark||Sr. VP of Global Commercialization||235k||N/A||N/A|
TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. In addition, it offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices. TSO3 Inc. was founded in 1998 and is headquartered in Quebec, Canada.
TSO3 Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.